News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
247 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18908)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Cryogenic Logistics Company CryoPort Grabs Contracts for Gilead, Novartis CAR-T Products
CryoPort handles the products for more than 172 of the more than 800 immunotherapy trials underway.
November 1, 2017
·
3 min read
·
Alex Keown
Business
Novartis Scientist Wounded in NYC Terrorist Attack That Killed Eight People
The scientist was among the nearly one dozen people injured on Oct. 31.
November 1, 2017
·
2 min read
·
Alex Keown
Business
Arbutus Announces Conference Call to Provide a Corporate Update and Third Quarter 2017 Financial Results
The company will host a conference call to provide a corporate update.
November 1, 2017
·
1 min read
Business
Cambridge’s Proteostasis Slashes R&D Jobs in Focus Shift
As part of a strategic restructuring, Proteostasis is laying off 13 members of its R&D workforce.
November 1, 2017
·
2 min read
·
Mark Terry
Pharm Country
ASH 2017: Janssen to Present 40 Abstracts, Including 8 Oral Presentations, With New Data on DARZALEX (Daratumumab), IMBRUVICA (Ibrutinib) and Other Compounds From Robust Portfolio
New data for the immunotherapy DARZALEX (daratumumab) and first-in-class BTK inhibitor IMBRUVICA (ibrutinib) are among eight oral presentations from Janssen Research & Development, LLC, to be featured at the 59th American Society of Hematology Annual Meeting & Exhibition taking place December 9-12, in Atlanta, GA.
November 1, 2017
·
40 min read
Business
Amarin Reports Third Quarter 2017 Financial Results and Provides Update on Operations
Net product revenue in the third quarter of 2017 achieved record levels.
November 1, 2017
·
17 min read
Dotmatics Announces Immediate Availability of 5.2 Informatics Suite With Major New Chemistry, Reaction Workflows and Register Capabilities
Dotmatics announced Version 5.2, a new release of the company’s informatics suite designed to enhance the end user experience and make scientists more productive.
November 1, 2017
·
3 min read
Previous
25 of 25